PedAM
Pediatric Disease Annotations & Medicines
| Disease | cystic fibrosis |
| Symptom | |infections |
| Sentences | 173 |
| PubMedID- 19939932 | The burkholderia cepacia complex (bcc) is made up of at least 17 species of gram-negative opportunistic bacterial pathogens that cause fatal infections in patients with cystic fibrosis and chronic granulomatous disease. |
| PubMedID- 21555402 | Pseudomonas aeruginosa, an opportunistic pathogen of clinical importance, causes chronic airway infections in patients with cystic fibrosis (cf). |
| PubMedID- 24232573 | Samples from wound infections and lungs of patients with cystic fibrosis often contains both p. aeruginosa and s. aureus, underscoring the clinical importance of co-infection by these two bacteria.24,25 it has been shown that interaction of p. aeruginosa and gram-positive bacteria including s. aureus can lead to increased virulence in p. aeruginosa.26 there is little information available about the interaction between these two bacterial pathogens and the importance of this interaction with regards to the severity and outcome of infection. |
| PubMedID- 23281188 | In chronic lung infections of people with cystic fibrosis, p. aeruginosa inhabits viscous, adhesive mucus, which likely retards the diffusion of secreted molecules. |
| PubMedID- 25590983 | Rationale: pseudomonas aeruginosa, the predominant cause of chronic airway infections of patients with cystic fibrosis, exhibits extensive phenotypic diversity among isolates within and between sputum samples, but little is known about the underlying genetic diversity. |
| PubMedID- 24575808 | This method has been effectively used for treatment of tuberculosis, leprosy, malaria, hiv, infections associated with cystic fibrosis, and infective endocarditis . |
| PubMedID- 23481089 | However whether and how it can be used for the treatment of bacterial lung infections in patients with cystic fibrosis is unclear. |
| PubMedID- 21991261 | For example, p. aeruginosa isolates obtained from chronic pulmonary infections of patients with cystic fibrosis (cf) are often mucoid. |
| PubMedID- 25666799 | Alginate is one of the three major pseudomonas exopolysaccharides, and it is only produced by mucoid strains that establish chronic infections in patients with cystic fibrosis (cf). |
| PubMedID- 25036925 | Chronic bacterial lung infections associated with non-cystic fibrosis bronchiectasis represent a substantial and growing health-care burden. |
| PubMedID- 25657265 | Pandoraea is an emerging respiratory pathogen capable of causing chronic lung infections in people with cystic fibrosis (cf), but the clinical significance of this infection is ambiguous. |
| PubMedID- 23829476 | Burn victims and cystic fibrosis patients ), with infections being initiated through interaction of t4p with cellular receptors . |
| PubMedID- 24367355 | This genus includes several human pathogens among them the burkholderia cepacia complex, which are particularly important for causing chronic opportunistic infections especially in patients with cystic fibrosis or chronic granulomatous disease (mahenthiralingam et al., 2005; loutet and valvano, 2011). |
| PubMedID- 23910799 | Pseudomonas aeruginosa infections are commonly associated with cystic fibrosis, pneumonias, neutropenia and burns. |
| PubMedID- 24040015 | B. multivorans is recognized as an important pathogen in nosocomial infections of patients with cystic fibrosis , although it has not been linked to an arthropod vector. |
| PubMedID- 25861288 | During the last 2 decades, colistin was mainly restricted to treat acute exacerbations of lung infections in patients with cystic fibrosis . |
| PubMedID- 25533880 | Among several inhaled beta-lactams, ceftazidime was used with varying success in the prevention and treatment of ventilator-associated pneumonia (vap) and improved clinical outcomes in chronic pseudomonas aeruginosa lower respiratory tract infections (lrtis) in patients with cystic fibrosis (cf) or bronchiectasis. |
| PubMedID- 24452385 | The effect of the weather on pulmonary exacerbations and viral infections among adults with cystic fibrosis. |
| PubMedID- 24704788 | In fact, biofilm communities exhibit increased tolerance towards conventional anti-microbial treatments and sterilization techniques and are responsible for many chronic infections associated with cystic fibrosis and endocarditis6,7 as well as nosocomial infections8. |
| PubMedID- 21926193 | Although only poorly documented, it can be assumed that intensive antibiotic treatments of chronic lung infections in patients with cystic fibrosis (cf) also affect the diversity and metabolic functioning of the gastrointestinal microbiota and potentially lead to a state of dysbiosis. |
| PubMedID- 24119232 | Strains of the burkholderia cepacia complex (bcc) are opportunistic pathogens that cause life-threatening infections in patients with cystic fibrosis (cf) and chronic granulomatous disease (cgd). |
| PubMedID- 24461904 | Respiratory infections in patients with cystic fibrosis undergoing lung transplantation. |
| PubMedID- 22848580 | Burkholderia cenocepacia belongs to the burkholderia cepacia complex (bcc) . |